{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:14:10Z","timestamp":1789370050572,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.1038\/sj.bmt.1703255","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:39:28Z","timestamp":1032280768000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?"],"prefix":"10.1038","volume":"28","author":[{"given":"JW","family":"Sweetenham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,11,26]]},"reference":[{"key":"BF1703255_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","volume":"6","author":"DA Stewart","year":"1995","unstructured":"Stewart DA, Vose JM, Weisenberger DD et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma Ann Oncol 1995 6: 263\u2013266","journal-title":"Ann Oncol"},{"key":"BF1703255_CR2","first-page":"1975","volume":"10","author":"R Haas","year":"1996","unstructured":"Haas R, Brittinger G, Meusers P et al. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma Leukemia 1996 10: 1975\u20131979","journal-title":"Leukemia"},{"key":"BF1703255_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1023\/A:1008251301319","volume":"8","author":"P Dreger","year":"1997","unstructured":"Dreger P, von Neuhoff N, Kuse R et al. Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma Ann Oncol 1997 8: 401\u2013403","journal-title":"Ann Oncol"},{"key":"BF1703255_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1023\/A:1008278605751","volume":"8","author":"N Ketterer","year":"1997","unstructured":"Ketterer N, Salles G, Espinouse D et al. Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma Ann Oncol 1997 8: 701\u2013704","journal-title":"Ann Oncol"},{"key":"BF1703255_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/sj.bmt.1701033","volume":"21","author":"N Kroger","year":"1998","unstructured":"Kroger N, Hoffneckht M, Dreger P et al. Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy Bone Marrow Transplant 1998 21: 55\u201357","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sj.bmt.1701046","volume":"21","author":"J-Y Blay","year":"1998","unstructured":"Blay J-Y, Sebban C, Surbiguet C et al. High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin's lymphomas: a single center experience on 18 patients Bone Marrow Transplant 1998 21: 51\u201354","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","volume":"22","author":"N Milpied","year":"1998","unstructured":"Milpied N, Gaillard F, Moreau P et al. High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience Bone Marrow Transplant 1998 22: 645\u2013650","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","volume":"16","author":"AS Freedman","year":"1998","unstructured":"Freedman AS, Neuberg D, Gribben JG et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle cell lymphoma: no evidence for long-term remission J Clin Oncol 1998 16: 13\u201318","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR9","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Romaguera J, Kantarjian H et al. Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem cell transplantation: an active regimen for aggressive mantle cell lymphoma J Clin Oncol 1998 16: 3803\u20133809","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1083-8791(00)70030-9","volume":"6","author":"JM Vose","year":"2000","unstructured":"Vose JM, Bierman PJ, Weisenberger DD et al. Autologous hematopoietic stem cell transplantation for mantle cell lymphoma Biol Blood Marrow Transplant 2000 6: 640\u2013645","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703255_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/sj.bmt.1702135","volume":"25","author":"D Decaudin","year":"2000","unstructured":"Decaudin D, Brousse N, Brice P et al. Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3 year follow up study Bone Marrow Transplant 2000 25: 251\u2013256","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2141.1996.d01-1816.x","volume":"94","author":"P Corradini","year":"1996","unstructured":"Corradini P, Ladetto M, Astolfi M et al. Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle cell lymphoma Br J Haematol 1996 94: 376\u2013378","journal-title":"Br J Haematol"},{"key":"BF1703255_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s002770000196","volume":"79","author":"N Kroger","year":"2000","unstructured":"Kroger N, Hoffnecht M, Kruger W et al. Allogeneic bone marrow transplantation for refractory mantle cell lymphoma Ann Hematol 2000 79: 578\u2013580","journal-title":"Ann Hematol"},{"key":"BF1703255_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.bmt.1702567","volume":"26","author":"C Martinez","year":"2000","unstructured":"Martinez C, Carreras E, Rovira M et al. Patients with mantle cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation Bone Marrow Transplant 2000 26: 677\u2013679","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1023\/A:1008380527502","volume":"10","author":"IF Khouri","year":"1999","unstructured":"Khouri IF, Lee M-S, Romaguera J et al. Allogeneic hematopoietic transplantation for mantle cell lymphoma: molecular remissions and evidence of graft-versus-malignancy Ann Oncol 1999 10: 1293\u20131299","journal-title":"Ann Oncol"},{"key":"BF1703255_CR16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361\u20131392","journal-title":"Blood"},{"key":"BF1703255_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J et al. The World Health Organization Classification of Diseases of the Hematopoietic and Lymphoid Systems Ann Oncol 1999 10: 1419\u20131432","journal-title":"Ann Oncol"},{"key":"BF1703255_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","volume":"5","author":"E Zucca","year":"1994","unstructured":"Zucca E, Stein H, Coiffer B . European Lymphoma Task force (ELTF): report of the workshop on mantle cell lymphoma (MCL) Ann Oncol 1994 5: 507\u2013511","journal-title":"Ann Oncol"},{"key":"BF1703255_CR19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","volume":"85","author":"RI Fisher","year":"1995","unstructured":"Fisher RI, Dahlberg S, Nathwani BN et al. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study Blood 1995 85: 1075\u20131082","journal-title":"Blood"},{"key":"BF1703255_CR20","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1200\/JCO.1995.13.11.2819","volume":"13","author":"I Teodorovic","year":"1995","unstructured":"Teodorovic I, Pittaluga S, Kluin-Nelemans JC et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes J Clin Oncol 1995 13: 2819\u20132826","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","volume":"6","author":"AJ Norton","year":"1995","unstructured":"Norton AJ, Matthews J, Pappa V et al. Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period Ann Oncol 1995 6: 249\u2013256","journal-title":"Ann Oncol"},{"key":"BF1703255_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","volume":"14","author":"GA Velders","year":"1996","unstructured":"Velders GA, Kluin-Nelemans JC, De Boer CJ et al. Mantle-cell lymphoma: a population-based study J Clin Oncol 1996 14: 1269\u20131274","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","volume":"6","author":"E Zucca","year":"1996","unstructured":"Zucca E, Roggero E, Pinotti G et al. Patterns of survival in mantle cell lymphoma Ann Oncol 1996 6: 257\u2013262","journal-title":"Ann Oncol"},{"key":"BF1703255_CR24","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","volume":"87","author":"DD Weisenberger","year":"1996","unstructured":"Weisenberger DD, Armitage JO . Mantle cell lymphoma \u2013 an entity comes of age Blood 1996 87: 4483\u20134494","journal-title":"Blood"},{"key":"BF1703255_CR25","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.1997.15.4.1664","volume":"15","author":"A Majlis","year":"1997","unstructured":"Majlis A, Pugh WH, Rodriguez MA et al. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants J Clin Oncol 1997 15: 1664\u20131671","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1200\/JCO.1996.14.3.941","volume":"14","author":"E Montserrat","year":"1996","unstructured":"Montserrat E, Bosch F, Lopez-Guillermo A et al. CNS involvement in mantle cell lymphoma J Clin Oncol 1996 14: 941\u2013944","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR27","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases Blood 1997 89: 2067\u20132078","journal-title":"Blood"},{"key":"BF1703255_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0959-8049(97)10056-9","volume":"34","author":"R Oinonen","year":"1998","unstructured":"Oinonen R, Franssila K, Teerenhovi et al. Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients Eur J Cancer 1998 34: 329\u2013366","journal-title":"Eur J Cancer"},{"key":"BF1703255_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","volume":"82","author":"F Bosch","year":"1998","unstructured":"Bosch F, Lopez-Guillermo A, Campo E et al. Mantle cell lymphoma. Presenting features, response to therapy and prognostic factors Cancer 1998 82: 567\u2013575","journal-title":"Cancer"},{"key":"BF1703255_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/1096-8652(200007)64:3<190::AID-AJH9>3.0.CO;2-B","volume":"64","author":"DD Weisenberger","year":"2000","unstructured":"Weisenberger DD, Vose JM, Greiner TC et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group Am J Hematol 2000 64: 190\u2013196","journal-title":"Am J Hematol"},{"key":"BF1703255_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1365-2141.1997.4693273.x","volume":"99","author":"E Vandenberghe","year":"1999","unstructured":"Vandenberghe E, De Wolf-Peeters C, Vaughan-Hudson G et al. The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group Br J Haematol 1999 99: 842\u2013847","journal-title":"Br J Haematol"},{"key":"BF1703255_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","volume":"18","author":"JM Foran","year":"2000","unstructured":"Foran JM, Rohatiner AZS, Cunningham D et al. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle cell lymphoma and previously treated mantle cell lymphoma, immunocytoma and small B-cell lymphocytic lymphoma J Clin Oncol 2000 18: 317\u2013324","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1023\/A:1008309405678","volume":"11","author":"JM Foran","year":"2000","unstructured":"Foran JM, Cunningham D, Coiffier B et al. Treatment of mantle cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response Ann Oncol 2000 11: (Suppl. 1) 117\u2013121","journal-title":"Ann Oncol"},{"key":"BF1703255_CR34","first-page":"631a","volume":"94","author":"O Howard","year":"1999","unstructured":"Howard O, Gribben JG, Neuberg D et al. Rituxan\/CHOP induction therapy in newly diagnosed patients with mantle cell lymphoma Blood 1999 94: 631a (Abstr.)","journal-title":"Blood"},{"key":"BF1703255_CR35","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","volume":"87","author":"L Hernandez","year":"1996","unstructured":"Hernandez L, Fest T, Cazorla M et al. P53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas Blood 1996 87: 3351\u20133359","journal-title":"Blood"},{"key":"BF1703255_CR36","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","volume":"87","author":"TC Greiner","year":"1996","unstructured":"Greiner TC, Moynihan MJ, Chan WC et al. P53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis Blood 1996 87: 4302\u20134310","journal-title":"Blood"},{"key":"BF1703255_CR37","first-page":"2253","volume":"95","author":"Y Yatabe","year":"2000","unstructured":"Yatabe Y, Suzuki R, Tobinai K et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive and cyclin D1-negative MCL-like B-cell lymphoma Blood 2000 95: 2253\u20132261","journal-title":"Blood"},{"key":"BF1703255_CR38","doi-asserted-by":"crossref","unstructured":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin's lymphoma New Engl J Med 1993 329: 987\u2013994","DOI":"10.1056\/NEJM199309303291402"},{"key":"BF1703255_CR39","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"JO Armitage","year":"1998","unstructured":"Armitage JO, Weisenberger DD . New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes J Clin Oncol 1998 16: 2780\u20132795","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR40","first-page":"482a","volume":"96","author":"E Vandenberghe","year":"2000","unstructured":"Vandenberghe E, Ruiz de Elvira C, Isaacson P et al. Does transplantation improve outcome in mantle cell lymphoma (MCL)? A study from the EBMT Blood 2000 96: 482a (Abstr.)","journal-title":"Blood"},{"key":"BF1703255_CR41","first-page":"13a","volume":"20","author":"JM Malone","year":"2001","unstructured":"Malone JM, Molina A, Stockerl-Goldstein K et al. High dose therapy and autologous hematopoietic cell transplantation for mantle cell lymphoma: the Stanford\/City of Hope experience Proc Am Soc Clin Oncol 2001 20: 13a (Abstr.)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1703255_CR42","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"Project The Non-Hodgkin's Lymphoma Classifi","year":"1997","unstructured":"The Non-Hodgkin's Lymphoma Classification Project . A clinical evaluation of the International Lymphoma Study Group Blood 1997 89: 3909\u20133918","journal-title":"Blood"},{"key":"BF1703255_CR43","first-page":"733a","volume":"96","author":"JE Romaguera","year":"2000","unstructured":"Romaguera JE, Dang NH, Hagemeister FB et al. Preliminary report of rituximab with intensive chemotherapy for untreated aggressive mantle cell lymphoma (MCL) Blood 2000 96: 733a (Abstr.)","journal-title":"Blood"},{"key":"BF1703255_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/sj.bmt.1701637","volume":"23","author":"C Jacquy","year":"1999","unstructured":"Jacquy C, Lambert F, Soree A et al. Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging? Bone Marrow Transplant 1999 23: 681\u2013686","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR45","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","volume":"90","author":"NS Andersen","year":"1997","unstructured":"Andersen NS, Donovan JW, Borus JS et al. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease Blood 1997 90: 4212\u20134221","journal-title":"Blood"},{"key":"BF1703255_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2141.2000.01965.x","volume":"109","author":"JM Foran","year":"2000","unstructured":"Foran JM, Gupta RK, Cunningham D et al. Immunotherapy of follicular lymphoma with rituximab (chimeric anti-CD20 monoclonal antibody): a UK phase II trial with monitoring of molecular response Br J Haematol 2000 109: 81\u201388","journal-title":"Br J Haematol"},{"key":"BF1703255_CR47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","volume":"96","author":"M Magni","year":"2000","unstructured":"Magni M, Di Nicola M, Devizzi L et al. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence foe a role of both chemotherapy and rituximab infusion Blood 2000 96: 864\u2013869","journal-title":"Blood"},{"key":"BF1703255_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","volume":"19","author":"KW Van Besien","year":"1997","unstructured":"Van Besien KW, De Lima M, Giralt S et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect Bone Marrow Transplant 1997 19: 977\u2013982","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR49","first-page":"669","volume":"18","author":"G Rondon","year":"1996","unstructured":"Rondon G, Giralt S, Huh Y et al. Graft-versus- leukemia after allogeneic bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplant 1996 18: 669\u2013672","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR50","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 1998 16: 2817\u20132824","journal-title":"J Clin Oncol"},{"key":"BF1703255_CR51","first-page":"17a","volume":"17","author":"SK Sohn","year":"1997","unstructured":"Sohn SK, Bensinger W, Holmberg L et al. High-dose chemotherapy with allogeneic or autologous stem cell transplantation for relapsed mantle cell lymphoma: the Seattle experience Proc Am Soc Clin Oncol 1997 17: 17a (Abstr.)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1703255_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.bmt.1701044","volume":"21","author":"D Adkins","year":"1998","unstructured":"Adkins D, Brown R, Goodnough LT et al. Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation Bone Marrow Transplant 1998 21: 97\u201399","journal-title":"Bone Marrow Transplant"},{"key":"BF1703255_CR53","first-page":"459a","volume":"92","author":"A Molina","year":"1998","unstructured":"Molina A, Nademanee A, O'Donnell MR et al. Autologous and allogeneic stem-cell transplantation for poor-risk mantle cell lymphoma: the City of Hope experience Blood 1998 92: 459a (Abstr.)","journal-title":"Blood"},{"key":"BF1703255_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/1096-8652(200009)65:1<75::AID-AJH14>3.0.CO;2-L","volume":"65","author":"SK Sohn","year":"2000","unstructured":"Sohn SK, Baek JH, Kim DH et al. Successful allogeneic stem-cell transplantation with prophylactic stepwise G-CSF primed DLIs for relapse after autologous transplantation in mantle cell lymphoma: a case report and literature review on the evidence of GVL effects in MCL Am J Hematol 2000 65: 75\u201380","journal-title":"Am J Hematol"},{"key":"BF1703255_CR55","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood.V96.9.2934","volume":"96","author":"OW Press","year":"2000","unstructured":"Press OW, Eary JF, Gooley T et al. A phase I\/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas Blood 2000 96: 2934\u20132942","journal-title":"Blood"},{"key":"BF1703255_CR56","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/3266","volume":"4","author":"CA King","year":"1998","unstructured":"King CA, Spellerberg MB, Ziiu D et al. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma Nat Med 1998 4: 1281\u20131286","journal-title":"Nat Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703255","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:24:47Z","timestamp":1648074287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["BF1703255"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703255","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,1]]},"assertion":[{"value":"26 November 2001","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}